Flash Finance

Q2 FY26 quarterly results (July-September 2025)

5,073 companies have declared Q2 FY26 results so far, the latest on 14 Sep 2026.

Across the 4,407 non-financial companies with a year-ago quarter to compare, sales grew +12.8% and net profit +57.5% year on year, and the combined operating margin widened 96 bps to 14.3%.

For the 146 banks and lenders, net interest income grew +6.3% and net profit +7.3%.

54% of companies grew net profit; 337 turned a loss into a profit; 34% beat their own profit trend and 50% fell short of it.

Updated 20 Oct 2026, 13:17 IST 5073 declared
The next results season has started: 166 companies have filed results for the quarter ended 30 Sep 2026. See them →

Q2 FY26 scoreboard

Sales growth
+12.8%
YoY, 4407 companies combined; median +8.4%
Net profit growth
+57.5%
YoY combined; median +9.4%
Operating margin
14.3%
+96 bps YoY
Grew profit
54%
337 turnarounds, 405 into loss
Vs own profit trend
34% / 50%
above / below, 16% in line
Banks: NII growth
+6.3%
146 lenders; profit +7.3%
Price since results
-10.0%
median; 0% of 1 stocks up
Other-income heavy
1339
25%+ of pre-tax profit from other income & one-offs

Latest Q2 FY26 results 5073

Page 117 of 170

Sikozy Realtors Ltd

524642 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —— 0.00.00.0
Operating profit loss widened— -0.0-0.0-0.0
Other income —— 0.00.00.0
Net profit loss widenedloss widened -0.1-0.0-0.0
EPS (₹) —loss widened -0.02-0.010.00

Quality of profit

Pre-tax profit −₹0.1 Cr: core business −₹0.1 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY25 cash from operations −₹0.2 Cr.

Borrowings ₹0.3 Cr at Mar 2025.

Welcure Drugs & Pharmaceuticals Ltd

524661 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin expanded 867 bps YoY
  • Core business grew faster than reported profit (core profit +450%)
  • Operating cash flow was negative in FY25 despite a profit
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +164.0%-78.0% 66.030025.0
Operating profit +450.0%-64.5% 11.031.02.0
OPM % +867 bps+633 bps 16.7%10.3%8.0%
Other income —— 0.00.00.0
Net profit +300.0%-65.2% 8.023.02.0
PAT margin % +412 bps+445 bps 12.1%7.7%8.0%
EPS (₹) —-63.2% 0.070.190.01

No EPS growth against Sep 2024: 1:10 bonus in Oct 2025 and ₹10 to ₹1 split in Oct 2025.

Quality of profit

Core 100%Other income & one-offs 0%

Pre-tax profit ₹11.0 Cr: core business ₹11.0 Cr, other income ₹0.0 Cr.

Core profit YoY: +450.0% · reported profit +300.0%

Cash & debt

FY25 cash from operations −₹222 Cr: -4440% of FY25 net profit of ₹5.0 Cr.

Borrowings ₹123 Cr at Mar 2025.

Kabsons Industries Ltd

524675 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -101% below its own trend
  • Operating margin contracted 455 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +6.6%+4.4% 10.610.19.9
Operating profit -69.8%-72.5% 0.20.70.6
OPM % -455 bps-501 bps 1.8%6.8%6.3%
Other income -92.4%-82.4% 0.10.51.2
Net profit to lossto loss -0.00.81.5
PAT margin % -1559 bps-867 bps -0.3%8.4%15.3%
EPS (₹) to lossto loss -0.020.490.87

Quality of profit

Pre-tax profit −₹0.0 Cr: core business −₹0.1 Cr, other income ₹0.1 Cr.

Core profit YoY: to loss

Cash & debt

FY25 cash from operations ₹2.5 Cr: 123% of FY25 net profit of ₹2.1 Cr.

Borrowings ₹0.3 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹13.3₹10.6 -20.6% below
Net profit₹2.2−₹0.0 -101.3% below

Basant Agro Tech India Ltd

524687 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +354% above its own trend
  • Core business grew faster than reported profit (core profit +243%)
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +25.8%-40.0% 10617684.1
Operating profit +12.2%-25.0% 6.58.75.8
OPM % -75 bps+124 bps 6.2%4.9%6.9%
Other income -66.7%+0.0% 0.00.00.1
Net profit +188.2%-61.1% 1.02.50.3
PAT margin % +52 bps-50 bps 0.9%1.4%0.4%
EPS (₹) +175.0%-60.7% 0.110.280.04

Quality of profit

Core 98%Other income & one-offs 2%

Pre-tax profit ₹1.1 Cr: core business ₹1.0 Cr, other income ₹0.0 Cr.

Core profit YoY: +243.3% · reported profit +188.2%

Cash & debt

FY25 cash from operations ₹44.0 Cr: 1058% of FY25 net profit of ₹4.2 Cr.

Borrowings ₹131 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹91.7₹106 +15.5% above
Net profit₹0.2₹1.0 +353.5% above

Sandu Pharmaceuticals Ltd

524703 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -0.5%+5.5% 17.616.717.7
Operating profit -6.5%+62.3% 0.90.50.9
OPM % -32 bps+171 bps 4.9%3.2%5.2%
Other income +66.7%+150.0% 0.10.00.0
Net profit +4.0%+136.4% 0.50.20.5
PAT margin % +13 bps+163 bps 3.0%1.3%2.8%
EPS (₹) +3.8%+134.8% 0.540.230.52

Quality of profit

Core 93%Other income & one-offs 7%

Pre-tax profit ₹0.7 Cr: core business ₹0.7 Cr, other income ₹0.1 Cr.

Core profit YoY: -8.3% · reported profit +4.0%

Cash & debt

FY25 cash from operations ₹0.9 Cr: 61% of FY25 net profit of ₹1.6 Cr.

Borrowings nil at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹18.0₹17.6 -2.1% in line
Net profit₹0.6₹0.5 -5.6% in line

Vista Pharmaceuticals Ltd

524711 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -41.4%-3.9% 1.51.52.5
Operating profit loss widenedloss widened -3.4-1.1-0.8
Other income —— 0.20.00.0
Net profit loss widenedloss widened -2.6-1.3-1.0
EPS (₹) loss widenedloss widened -0.42-0.21-0.26

Quality of profit

Pre-tax profit −₹3.6 Cr: core business −₹3.8 Cr, other income ₹0.2 Cr.

Core profit YoY: loss widened

Cash & debt

FY25 cash from operations −₹7.0 Cr.

Borrowings ₹7.0 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹2.3₹1.5 -37.5% below

Titan Biotech Ltd

524717 · Q2 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +26% above its own trend
  • Operating margin contracted 229 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +36.2%+16.9% 54.446.539.9
Operating profit +20.2%+6.8% 9.38.77.8
OPM % -229 bps-163 bps 17.2%18.8%19.5%
Other income +312.5%+83.3% 1.30.70.3
Net profit? +15.8%+13.1% 7.86.96.7
PAT margin % -252 bps-47 bps 14.3%14.8%16.8%
EPS (₹) +16.0%+13.3% 1.881.661.62

Quality of profit

Core 86%Other income & one-offs 14%

Pre-tax profit ₹9.2 Cr: core business ₹7.9 Cr, other income ₹1.3 Cr.

Core profit YoY: +23.6% · reported profit +15.8%

Cash & debt

FY25 cash from operations ₹20.0 Cr: 93% of FY25 net profit of ₹21.5 Cr.

Borrowings ₹3.0 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹35.9₹54.4 +51.4% above
Net profit₹6.2₹7.8 +26.1% above

Arvaya Healthcare Ltd

524723 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -100.0%— 0.00.00.1
Operating profit loss widenedloss widened -0.3-0.3-0.2
Other income -50.0%-33.3% 0.00.00.0
Net profit loss widenedloss widened -0.3-0.2-0.1
EPS (₹) loss narrowedloss widened -0.41-0.33-0.47

Quality of profit

Pre-tax profit −₹0.3 Cr: core business −₹0.3 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY25 cash from operations ₹0.2 Cr: 169% of FY25 net profit of ₹0.1 Cr.

Borrowings nil at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹0.1₹0.0 -100.0% below

Span Divergent Ltd

524727 · Q2 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Operating margin contracted 857 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +173.2%+615.0% 7.71.12.8
Operating profit -100.0%loss narrowed 0.0-0.70.2
OPM % -857 bps+6168 bps 0.0%-61.7%8.6%
Other income -12.0%-75.8% 0.20.90.2
Net profit? to lossloss widened -0.2-0.20.1
PAT margin % -414 bps+1353 bps -2.4%-15.9%1.8%
EPS (₹) to lossloss widened -0.24-0.180.24

Quality of profit

Pre-tax profit −₹0.2 Cr: core business −₹0.4 Cr, other income ₹0.2 Cr.

Core profit YoY: loss widened

Cash & debt

FY25 cash from operations ₹1.9 Cr.

Borrowings ₹8.4 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹1.4₹7.7 +446.4% above

Jenburkt Pharmaceuticals Ltd

524731 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -21% below its own trend
  • Operating margin expanded 143 bps YoY
  • Core business grew faster than reported profit (core profit +20%)
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +12.2%+27.8% 46.036.041.0
Operating profit +18.2%+44.4% 13.09.011.0
OPM % +143 bps+326 bps 28.3%25.0%26.8%
Other income +0.0%+0.0% 2.02.02.0
Net profit +0.0%+25.0% 10.08.010.0
PAT margin % -265 bps-48 bps 21.7%22.2%24.4%
EPS (₹) +5.8%+30.4% 23.0217.6521.75

Quality of profit

Core 86%Other income & one-offs 14%

Pre-tax profit ₹14.0 Cr: core business ₹12.0 Cr, other income ₹2.0 Cr.

Core profit YoY: +20.0% · reported profit +0.0%

Cash & debt

FY25 cash from operations ₹28.0 Cr: 85% of FY25 net profit of ₹33.0 Cr.

Borrowings ₹4.0 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹43.7₹46.0 +5.3% above
Net profit₹12.7₹10.0 -21.3% below

Link Pharma Chem Ltd

524748 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 1166 bps YoY
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +31.0%-19.5% 6.37.84.8
Operating profit from loss-46.9% 0.30.6-0.3
OPM % +1166 bps-279 bps 5.4%8.2%-6.2%
Other income -86.1%-76.2% 0.10.20.4
Net profit from loss-95.0% 0.00.4-0.3
PAT margin % +678 bps-480 bps 0.3%5.1%-6.5%
EPS (₹) from loss-94.4% 0.050.90-0.70

Quality of profit

Pre-tax profit ₹0.0 Cr: core business −₹0.0 Cr, other income ₹0.1 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY25 cash from operations ₹2.7 Cr.

Borrowings ₹5.8 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹3.8₹6.3 +64.1% above

Decipher Labs Ltd

524752 · Q2 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 2544 bps YoY
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -26.6%+47.6% 4.32.95.9
Operating profit from lossfrom loss 0.1-3.3-1.3
OPM % +2544 bps— 2.8%—-22.7%
Other income -83.3%+100.0% 0.00.00.1
Net profit? from lossfrom loss 0.0-3.4-1.3
PAT margin % +2312 bps— 0.5%—-22.7%
EPS (₹) from lossfrom loss 0.02-3.40-1.32

Quality of profit

Pre-tax profit ₹0.0 Cr: core business −₹0.0 Cr, other income ₹0.0 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY25 cash from operations −₹9.8 Cr.

Borrowings ₹0.2 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹3.2₹4.3 +34.5% above

Emmessar Biotech & Nutrition Ltd

524768 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -72% below its own trend
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -73.5%+0.0% 0.10.10.3
Operating profit loss widenedloss widened -0.4-0.3-0.1
Other income +5.9%+1.9% 0.50.50.5
Net profit -60.7%-35.3% 0.10.20.3
EPS (₹) -60.7%-35.3% 0.220.340.56

Quality of profit

Pre-tax profit ₹0.1 Cr: core business −₹0.4 Cr, other income ₹0.5 Cr.

Core profit YoY: loss widened · reported profit -60.7%

Cash & debt

FY25 cash from operations ₹0.2 Cr: 69% of FY25 net profit of ₹0.3 Cr.

Borrowings nil at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹0.4₹0.1 -77.7% below
Net profit₹0.4₹0.1 -71.9% below

Everest Organics Ltd

524790 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -22% below its own trend
  • Operating margin expanded 227 bps YoY
  • Core business grew faster than reported profit (core profit +290%)
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +15.8%-5.2% 51.053.844.0
Operating profit +49.6%+15.5% 5.14.43.4
OPM % +227 bps+181 bps 10.1%8.3%7.8%
Other income +107.1%-47.3% 0.30.60.1
Net profit +56.8%-17.7% 1.21.40.7
PAT margin % +59 bps-35 bps 2.3%2.6%1.7%
EPS (₹) +29.3%-17.9% 1.191.450.92

Quality of profit

Core 89%Other income & one-offs 11%

Pre-tax profit ₹2.7 Cr: core business ₹2.4 Cr, other income ₹0.3 Cr.

Core profit YoY: +290.2% · reported profit +56.8%

Cash & debt

FY25 cash from operations −₹5.0 Cr.

Borrowings ₹48.0 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹37.3₹51.0 +36.9% above
Net profit₹1.5₹1.2 -21.6% below

Phyto Chem India Ltd

524808 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Operating margin contracted 2291 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -0.2%+190.7% 4.41.54.4
Operating profit to lossloss narrowed -0.4-0.50.6
OPM % -2291 bps+2457 bps -10.1%-34.7%12.8%
Other income —-22.5% 0.30.40.0
Net profit to lossloss widened -0.6-0.50.1
PAT margin % -1536 bps+1916 bps -12.8%-32.0%2.5%
EPS (₹) to lossloss widened -1.30-1.120.26

Quality of profit

Pre-tax profit −₹0.6 Cr: core business −₹0.9 Cr, other income ₹0.3 Cr.

Core profit YoY: to loss

Cash & debt

FY25 cash from operations ₹1.8 Cr.

Borrowings ₹15.8 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹2.5₹4.4 +71.0% above

Dynamic Industries Ltd

524818 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -60% below its own trend
  • 42% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -15.5%-19.7% 17.922.321.2
Operating profit -11.0%-37.3% 1.21.91.4
OPM % +34 bps-190 bps 6.8%8.7%6.4%
Other income +37.5%— 0.20.00.2
Net profit -20.0%-54.4% 0.40.80.5
PAT margin % -11 bps-153 bps 2.0%3.5%2.1%
EPS (₹) -20.1%-54.4% 1.192.611.49

Quality of profit

Core 58%Other income & one-offs 42%

Pre-tax profit ₹0.5 Cr: core business ₹0.3 Cr, other income ₹0.2 Cr.

Core profit YoY: -31.1% · reported profit -20.0%

Cash & debt

FY25 cash from operations ₹3.0 Cr: 191% of FY25 net profit of ₹1.6 Cr.

Borrowings ₹16.5 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹35.6₹17.9 -49.8% below
Net profit₹0.9₹0.4 -60.0% below

BDH Industries Ltd

524828 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +10% above its own trend
  • Operating margin contracted 123 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +16.8%+1.8% 19.018.616.2
Operating profit +9.2%+57.1% 3.32.13.0
OPM % -123 bps+618 bps 17.6%11.4%18.8%
Other income +27.9%+0.0% 0.60.60.4
Net profit +8.7%+43.2% 2.61.82.4
PAT margin % -103 bps+399 bps 13.8%9.8%14.8%
EPS (₹) +8.6%+43.1% 4.553.184.19

Quality of profit

Core 85%Other income & one-offs 15%

Pre-tax profit ₹3.6 Cr: core business ₹3.1 Cr, other income ₹0.6 Cr.

Core profit YoY: +10.8% · reported profit +8.7%

Cash & debt

FY25 cash from operations ₹15.0 Cr: 162% of FY25 net profit of ₹9.3 Cr.

Borrowings ₹1.0 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹13.0₹19.0 +45.3% above
Net profit₹2.4₹2.6 +10.3% above

Jauss Polymers Ltd

526001 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —— 0.00.00.0
Operating profit loss widened— -0.1-0.1-0.0
Other income —+0.0% 0.40.40.0
Net profit from loss+0.0% 0.30.3-0.0
EPS (₹) from loss+0.0% 0.690.69-0.06

Quality of profit

Pre-tax profit ₹0.3 Cr: core business −₹0.1 Cr, other income ₹0.4 Cr.

Core profit YoY: loss widened

Cash & debt

FY25 cash from operations −₹0.0 Cr.

Borrowings ₹0.4 Cr at Mar 2025.

Globus Constructors & Developers Ltd

526025 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —— 0.00.00.0
Operating profit —loss narrowed -0.1-0.1-0.1
Other income —-20.0% 0.10.10.0
Net profit loss narrowed— -0.0-0.0-0.1
EPS (₹) loss narrowed— 0.000.00-0.01

Quality of profit

Pre-tax profit −₹0.0 Cr: core business −₹0.1 Cr, other income ₹0.1 Cr.

Cash & debt

FY25 cash from operations ₹3.6 Cr: 102% of FY25 net profit of ₹3.5 Cr.

Borrowings nil at Mar 2025.

Polymechplast Machines Ltd

526043 · Q2 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -122% below its own trend
  • Operating margin contracted 418 bps YoY
  • All of pre-tax profit came from other income or one-off items
  • Operating cash flow was negative in FY25 despite a profit
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -8.7%+25.0% 15.012.016.4
Operating profit -81.4%from loss 0.2-0.20.9
OPM % -418 bps+307 bps 1.1%-2.0%5.2%
Other income +9.5%+15.0% 0.20.20.2
Net profit? to lossloss narrowed -0.1-0.30.5
PAT margin % -371 bps+182 bps -0.6%-2.4%3.1%
EPS (₹) to lossloss narrowed -0.16-0.520.91

Quality of profit

Pre-tax profit ₹0.1 Cr: core business −₹0.1 Cr, other income ₹0.2 Cr.

Core profit YoY: to loss

Cash & debt

FY25 cash from operations −₹0.8 Cr: -119% of FY25 net profit of ₹0.7 Cr.

Borrowings ₹3.5 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹17.4₹15.0 -14.1% below
Net profit₹0.4−₹0.1 -122.5% below

Stellant Securities (India) Ltd

526071 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin contracted 488 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —— 41.02.01.0
Operating profit —— 39.02.01.0
OPM % -488 bps-488 bps 95.1%100.0%100.0%
Other income —— 0.00.00.0
Net profit —— 29.02.01.0
PAT margin % -2927 bps-2927 bps 70.7%100.0%100.0%
EPS (₹) —— adj. 15.800.920.58

EPS restated for the 4:1 bonus of Sep 2025: Sep 2025 ₹78.98 to ₹15.80. No EPS growth against Jun 2025: 4:1 bonus in Sep 2025.

Quality of profit

Core 100%Other income & one-offs 0%

Pre-tax profit ₹39.0 Cr: core business ₹39.0 Cr, other income ₹0.0 Cr.

Cash & debt

FY25 cash from operations ₹1.0 Cr: 100% of FY25 net profit of ₹1.0 Cr.

Borrowings nil at Mar 2025.

Galaxy Bearings Ltd

526073 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -162% below its own trend
  • Operating margin contracted 2487 bps YoY
  • Operating cash flow was negative in FY25 despite a profit
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -58.0%-10.6% 15.116.935.9
Operating profit to lossto loss -1.41.95.6
OPM % -2487 bps-2095 bps -9.4%11.5%15.5%
Other income to lossto loss -0.02.61.8
Net profit to lossto loss -2.12.64.7
PAT margin % -2740 bps-2957 bps -14.2%15.3%13.2%
EPS (₹) to lossto loss -6.768.1414.87

Quality of profit

Pre-tax profit −₹2.4 Cr: core business −₹2.4 Cr, other income −₹0.0 Cr.

Core profit YoY: to loss

Cash & debt

FY25 cash from operations −₹1.9 Cr: -14% of FY25 net profit of ₹13.7 Cr.

Borrowings ₹29.5 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹27.2₹15.1 -44.4% below
Net profit₹3.4−₹2.1 -162.4% below

Rekvina Laboratories Ltd

526075 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —— 0.20.00.0
Operating profit loss narrowedloss narrowed -0.0-0.0-0.1
OPM % —— -15.0%——
Other income —— 0.00.00.0
Net profit loss narrowedloss narrowed -0.0-0.0-0.1
PAT margin % —— -15.0%——
EPS (₹) loss narrowedloss narrowed -0.02-0.03-0.06

Quality of profit

Pre-tax profit −₹0.0 Cr: core business −₹0.0 Cr, other income ₹0.0 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY25 cash from operations −₹0.2 Cr.

Borrowings ₹0.2 Cr at Mar 2025.

SC Agrotech Ltd

526081 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —+134.6% 5.02.10.0
Operating profit from loss+833.3% 0.30.0-0.6
OPM % —+418 bps 5.6%1.4%—
Other income -100.0%— 0.00.00.4
Net profit from loss+950.0% 0.20.0-0.2
PAT margin % —+325 bps 4.2%0.9%—
EPS (₹) from loss— 0.350.03-0.32

Quality of profit

Core 100%Other income & one-offs 0%

Pre-tax profit ₹0.3 Cr: core business ₹0.3 Cr, other income ₹0.0 Cr.

Core profit YoY: from loss

Cash & debt

FY25 cash from operations ₹1.1 Cr: 555% of FY25 net profit of ₹0.2 Cr.

Borrowings nil at Mar 2025.

Ravileela Granites Ltd

526095 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 2266 bps YoY
  • 30% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +51.6%-3.6% 12.613.08.3
Operating profit +782.1%-27.9% 3.44.80.4
OPM % +2266 bps-921 bps 27.4%36.6%4.7%
Other income +128.6%+68.4% 1.00.60.4
Net profit from loss-25.2% 2.53.3-0.2
PAT margin % +2170 bps-566 bps 19.6%25.3%-2.1%
EPS (₹) from loss-25.3% 2.333.12-0.16

Quality of profit

Core 70%Other income & one-offs 30%

Pre-tax profit ₹3.2 Cr: core business ₹2.2 Cr, other income ₹1.0 Cr.

Core profit YoY: from loss

Cash & debt

FY25 cash from operations −₹2.3 Cr.

Borrowings ₹51.5 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹14.4₹12.6 -12.8% below

Uniroyal Marine Exports Ltd

526113 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 2026 bps YoY
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -9.1%+7.0% 4.94.65.4
Operating profit from loss-42.9% 0.10.1-1.0
OPM % +2026 bps-143 bps 1.6%3.1%-18.6%
Other income -71.1%+2.9% 0.30.31.2
Net profit from loss-53.3% 0.10.1-0.3
PAT margin % +721 bps-186 bps 1.4%3.3%-5.8%
EPS (₹) from loss-52.2% 0.110.23-0.48

Quality of profit

Pre-tax profit ₹0.1 Cr: core business −₹0.3 Cr, other income ₹0.3 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY25 cash from operations ₹1.3 Cr: 1340% of FY25 net profit of ₹0.1 Cr.

Borrowings ₹14.8 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹8.4₹4.9 -42.0% below

Karan Woo Sin Ltd

526115 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Operating cash flow was negative in FY25 despite a profit
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -100.0%— 0.00.01.4
Operating profit to lossloss widened -0.3-0.21.1
Other income -33.3%-33.3% 0.00.00.0
Net profit to lossloss widened -0.2-0.11.1
EPS (₹) to lossloss widened -0.30-0.181.36

Quality of profit

Pre-tax profit −₹0.2 Cr: core business −₹0.3 Cr, other income ₹0.0 Cr.

Core profit YoY: to loss

Cash & debt

FY25 cash from operations −₹1.8 Cr: -405% of FY25 net profit of ₹0.4 Cr.

Borrowings ₹0.6 Cr at Mar 2025.

Shervani Industrial Syndicate Ltd

526117 · Q2 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
  • Profit -147% below its own trend
  • Operating margin contracted 3945 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales -83.0%-62.1% 3.48.819.7
Operating profit to lossto loss -1.10.01.5
OPM % -3945 bps-3198 bps -31.6%0.3%7.8%
Other income +119.6%+33.3% 1.10.80.5
Net profit? to lossto loss -0.30.31.2
PAT margin % -1394 bps-1190 bps -8.1%3.8%5.9%
EPS (₹) to lossto loss -1.051.324.51

Quality of profit

Pre-tax profit −₹0.3 Cr: core business −₹1.4 Cr, other income ₹1.1 Cr.

Core profit YoY: to loss

Cash & debt

FY25 cash from operations ₹14.4 Cr: 373% of FY25 net profit of ₹3.8 Cr.

Borrowings ₹51.4 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹14.7₹3.4 -77.2% below
Net profit₹0.6−₹0.3 -146.6% below

BN Agrochem Ltd

526125 · Q2 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating cash flow was negative in FY25 despite a profit
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales —+6.5% 2162030.0
Operating profit from loss-94.6% 1.323.8-3.5
OPM % —-1112 bps 0.6%11.7%—
Other income —-100.0% 0.00.00.0
Net profit? from loss-10.8% 17.920.1-5.7
PAT margin % —-160 bps 8.3%9.9%—
EPS (₹) from loss-10.7% 1.832.05-5.75

Quality of profit

Pre-tax profit ₹0.6 Cr: core business ₹0.6 Cr, other income ₹0.0 Cr.

Core profit YoY: from loss

Cash & debt

FY25 cash from operations −₹31.0 Cr: -143% of FY25 net profit of ₹21.7 Cr.

Borrowings ₹83.0 Cr at Mar 2025.

Supertex Industries Ltd

526133 · Q2 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin expanded 113 bps YoY
₹ CrYoYQoQ Sep 2025Jun 2025Sep 2024
Sales +66.3%+152.6% 20.78.212.4
Operating profit +93.1%+479.3% 1.70.30.9
OPM % +113 bps+459 bps 8.1%3.5%7.0%
Other income —— 0.00.00.0
Net profit +10.7%from loss 0.6-0.40.6
PAT margin % -151 bps+752 bps 3.0%-4.5%4.5%
EPS (₹) +12.2%from loss 0.55-0.330.49

Quality of profit

Pre-tax profit ₹0.8 Cr: core business ₹0.8 Cr, other income ₹0.0 Cr.

Core profit YoY: — · reported profit +10.7%

Cash & debt

FY25 cash from operations ₹4.2 Cr.

Borrowings ₹21.4 Cr at Mar 2025.

Against its own trend ?

TrendActualGap
Sales₹6.2₹20.7 +232.7% above

How to read this page

The numbers. Each card is one company's Q2 FY26 results as filed with NSE or BSE, read from the filing within hours of its release, in ₹ crore. We show the consolidated statement, or the standalone one when the consolidated figures are a copy of it or have no year-ago quarter to compare with. YoY compares with the same quarter a year earlier and QoQ with the quarter before (the previous half-year for companies that report every six months). A swing between profit and loss is described in words: a percentage across it would mislead.

Net profit. On a consolidated statement, net profit is the profit of the whole group for the quarter, before minority interest. A company's own headline, and the AI read of its filing, often quote the profit attributable to its shareholders instead, which is lower when subsidiaries are partly owned: Larsen & Toubro's Q1 FY27 group profit was ₹4,988 Cr, of which ₹4,123 Cr belonged to its shareholders. EPS is worked out on that attributable profit, so EPS and net profit need not grow at the same rate. On a standalone statement the two are the same.

Margins. Operating margin (OPM) is operating profit, before depreciation, interest and other income, as a share of sales; PAT margin is net profit as a share of sales. Their changes are in basis points (100 bps = 1 percentage point).

Quality of profit. Core profit is operating profit minus interest and depreciation: what the business itself earned before tax. The rest of pre-tax profit is other income (interest on cash, dividends, gains on investments) and exceptional or one-off items. We flag a quarter when that share is 25% or more, and when reported profit grew much faster than core profit. For banks we compare pre-provision profit with net profit, since a fall in provisions can lift profit without the business growing.

Against its own trend. We do not have analyst consensus estimates, and we do not make them up. Instead each company is measured against the path it was on: the same quarter last year, grown at the median of its last four year-on-year growth rates (held between −50% and +100%; at least two growth rates needed). Sales 5% or more above that, or net profit 10% or more above, is "above trend"; as far below is "below trend". It answers "was this quarter better or worse than the company's own recent run?", which consensus does not.

Cash and debt. Profit is an accounting figure; cash is harder to dress up. For each company we show its operating cash flow for the last financial year as a share of that year's net profit (flagged under 50%, or when it is negative despite a profit), and its borrowings at the latest balance sheet against the one six months earlier (flagged at a 25% move). Balance sheets come with the September and March results, the year's cash-flow statement with the March results and the half-year's (April to September) with the September results.

Management guidance. When a company files the transcript of its earnings call, we read what its management said to expect: revenue or profit growth, margins, capex and the like, for this financial year or part of it. A figure is kept only when the sentence that states it is found in the transcript, and you can read it under "What management said". Growth and margins are then set beside the actual so far: the year-to-date quarters against the same quarters a year earlier (so the first half is measured against a full-year figure). Within 1 percentage point of the range for growth, or 0.5 for margins, is "on track"; above it "ahead", below it "behind". A new figure for the same period is marked raised or cut against the one before. This is what management said, not a forecast of ours.

Working capital. Inventory, trade receivables and trade payables from the same balance sheets, each also as days of sales (the amount against the twelve months' sales to that date, times 365). Receivables or inventory that grow 25 points or more faster than sales between two balance sheets (and by at least 20%) are flagged: money tied up in customers and stock is profit not yet in cash. These lines are read from filings since the September 2026 results, so comparisons with an earlier balance sheet start with the March 2027 results for most companies.

Price since results. The latest close against the last close before the filing (a filing after 3:30 pm counts from the next session). It is a fact about the market's reaction, not advice.

Market cap groups. Large cap is the 100 largest companies by market value and mid cap the next 150 (SEBI's ranking); below that, small cap is ₹5,000 Cr or more, micro cap ₹500 Cr or more, nano cap below.

Results calendarWho reports results today, tomorrow and this week. Strong quarterly resultsCompanies whose latest quarter showed profit up 30% or more. Live announcementsEvery NSE/BSE filing with an AI read, as it arrives. Company fundamentalsTen years of quarterly and annual financials.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI